RA
Rapport Therapeutics, Inc. Common Stock (RAPP)
NASDAQ·Healthcare·Biotechnology
$38.40
+8.82%
Mkt Cap $1.40B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (8 analysts)
$49.00
Range $40.00 – $66.00
Implied Upside
+27.6%
Consensus $49.00 vs current $38.40